Urgotul 99XX0071 Dressing, 5cm x 5cm, Pack of 10

Product Information

UrgoTul must not be used during hyperbaric oxygen chamber therapy without an oxygen mask (risk of combustion due to the presence of fat). When the gel‐forming agent comes into contact with wound fluid, it forms a gel‐like substance, which prevents escape of water vapour, thus maintaining a moist wound environment, beneficial for the healing process.

UrgoTul™ Ag - WoundSource UrgoTul™ Ag - WoundSource

If you are a patient with a wound, a carer for a patient, or if you simply want to learn more about wounds, our dedicated patients page has been developed to give you the information you need to understand wounds and healing.In the event of clinical signs of local infection, the doctor may decide to continue treatment using an antibacterial dressing. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. A randomised clinical trial comparing a hydrocolloid‐derived dressing and glycerol preserved allograft skin in the management of partial thickness burns. UrgoTul is produced using Lipido-Colloid Technology, an exclusive patented innovation from Laboratoires Urgo. Finally, UrgoStart is always used as part of a global management approach, along with appropriate etiological treatment.

Urgotul Absorb Foam Dressing - MedicalDressings Urgotul Absorb Foam Dressing - MedicalDressings

Other Single Use Instruments Curettes Needle Holders Probes Stitch Cutters Skin Staple Removers Proctology More. Twenty‐two percent versus 57% in the Urgotul ™ and TG‐dressed wounds gave patients ‘moderate pain’ and 35% of the TG‐dressed wounds were ‘very painful’ on dressing change.

UrgoTul may be left in place for up to 7 days dependent on wound condition and protocol (when prescribed with a compression bandage system for venous leg ulcers).

dressings without absorbent pad | Advanced wound Soft polymer dressings without absorbent pad | Advanced wound

If clinical signs of local infection are noted, treatment can be changed to an antibacterial dressing, dependent on clinical judgement. If an antiseptic has previously been used, rinse the wound carefully with normal saline before applying UrgoStart. UrgoClean has the ability to be left in place for up to 7 days, however during the early desloughing phase it may warrant more frequent dressing changes but this should be based on the clinical assessment. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers.

Sterile individual packaging, for single use: reuse of a disposable dressing can lead to risks of infection. In the event of an atypical ulcer demonstrating induration or excessive localised granulation, treatment with UrgoStart should only be started after having verified the absence of any ulcer deterioration, to prevent any delay in diagnosis. UrgoTul Absorb and UrgoTul Absorb Heel dressings should be changed every 2 to 4 days, depending on the exudate volume and the clinical condition of the wound.